1. Volume 137, Issue 6, Pages 2010-2017 (December 2009)
Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation 
Kymberly D.S. Watt, Rachel A. Pedersen, Walter K. Kremers, Julie K. Heimbach, William Sanchez, Gregory J. Gores 
Gastroenterology 
Volume 137, Issue 6, Pages (December 2009)
DOI: /j.gastro
Copyright © 2009 AGA Institute Terms and Conditions

2. Figure 1
Nonskin malignancy by underlying liver disease diagnosis. AIH, autoimmune hepatitis; ALD, alcohol-related liver disease; Crypt, cryptogenic cirrhosis; FHF, fulminant hepatic failure; HBV, hepatitis B virus; HCV, hepatitis C virus; Malig, malignancy; Metab, metabolic disease; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis. *3 cases with ALD and HCV included in ALD category.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

3. Figure 2
(A) and (B) Probability of developing de novo nonskin malignancy by underlying disease. 1a, hematologic malignancy, 1b, solid organ malignancy.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions

4. Figure 3
Probability of site-specific malignancies. GI, gastrointestinal; GU, female genitourinary; OP, oropharyngeal/laryngeal.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2009 AGA Institute Terms and Conditions